Loading...
Qiagen N.V.
QGEN•NYSE
Healthcare
Medical - Diagnostics & Research
$51.79
$0.56(1.09%)
Qiagen N.V. (QGEN) Financial Performance & Income Statement Overview
Review Qiagen N.V.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.66%
↑ 0.66%
Operating Income Growth
-78.05%
↓ 78.05%
Net Income Growth
-75.51%
↓ 75.51%
Operating Cash Flow Growth
46.60%
↑ 46.60%
Operating Margin
5.90%
↑ 5.90%
Gross Margin
50.006%
↑ 50.006%
Net Profit Margin
4.68%
↑ 4.68%
ROE
2.69%
↑ 2.69%
ROIC
2.35%
↑ 2.35%
Qiagen N.V. (QGEN) Income Statement & Financial Overview
Review Qiagen N.V.'s (QGEN) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $521.20M | $501.87M | $496.35M | $458.80M |
| Cost of Revenue | $171.40M | $193.56M | $461.58M | $170.53M |
| Gross Profit | $349.80M | $308.31M | $34.76M | $288.27M |
| Gross Profit Ratio | $0.67 | $0.61 | $0.07 | $0.63 |
| R&D Expenses | $48.60M | $44.45M | $49.10M | $51.33M |
| SG&A Expenses | $141.71M | $140.66M | $143.30M | $138.69M |
| Operating Expenses | $230.70M | $196.20M | $278.41M | $190.02M |
| Total Costs & Expenses | $402.10M | $389.77M | $724.78M | $360.55M |
| Interest Income | $15.09M | $18.25M | $16.91M | $17.76M |
| Interest Expense | $11.14M | $11.48M | $10.92M | $10.29M |
| Depreciation & Amortization | $45.55M | $49.99M | $53.39M | $54.33M |
| EBITDA | $182.55M | $177.93M | -$159.14M | $152.57M |
| EBITDA Ratio | $0.35 | $0.35 | -$0.32 | $0.33 |
| Operating Income | $119.10M | $112.10M | -$228.44M | $98.25M |
| Operating Income Ratio | $0.23 | $0.22 | -$0.46 | $0.21 |
| Other Income/Expenses (Net) | $6.75M | $4.35M | $4.99M | $4.04M |
| Income Before Tax | $125.85M | $116.46M | -$223.45M | $102.29M |
| Income Before Tax Ratio | $0.24 | $0.23 | -$0.45 | $0.22 |
| Income Tax Expense | $37.53M | $18.40M | -$39.99M | $21.62M |
| Net Income | $88.32M | $98.06M | -$183.46M | $80.67M |
| Net Income Ratio | $0.17 | $0.20 | -$0.37 | $0.18 |
| EPS | $0.41 | $0.44 | -$0.83 | $0.36 |
| Diluted EPS | $0.40 | $0.44 | -$0.83 | $0.36 |
| Weighted Avg Shares Outstanding | $216.12M | $222.31M | $221.99M | $221.85M |
| Weighted Avg Shares Outstanding (Diluted) | $218.02M | $224.03M | $221.99M | $226.57M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan